Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02831972 · ClinicalTrials.gov registry record · Phase 1
Drug-Drug Interaction Study of AG120 in Healthy Subjects
A Phase 1 study, sponsored by Agios Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT02831972 is a Phase 1 study that has completed, run by Agios Pharmaceuticals. The registered enrollment target is 22 participants.
The verdict
NCT02831972, a Phase 1 study, has completed, sponsored by Agios Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
An Open-Label, 2-Period, Fixed Sequence Study to Determine the Effect of Multiple Oral Doses of Itraconazole on the Single Dose Pharmacokinetics of AG 120 in Healthy Adult Subjects. Period 1 consists of a single oral dose of AG-120 will be administered at Hour 0 followed by PK sampling for 504 hours (21 days). In Period 2, multiple oral doses of itraconazole will be administered once daily (QD) for 18 consecutive days with a single oral dose of AG-120 coadministered at Hour 0 on Day 1. PK sampling for AG-120 will be taken for 504 hours (21 days) following AG-120 dosing on Day 1.
Interventions
- DRUG Itraconazole
- DRUG AG120
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02831972
The ClinicalTrials.gov registry entry for NCT02831972 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agios Pharmaceuticals, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Itraconazole is the first listed.
NCT02831972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02831972 about?
NCT02831972 is a clinical study titled "Drug-Drug Interaction Study of AG120 in Healthy Subjects". An Open-Label, 2-Period, Fixed Sequence Study to Determine the Effect of Multiple Oral Doses of Itraconazole on the Single Dose Pharmacokinetics of AG 120 in Healthy Adult Subjects. Period 1 consists of a single oral dose of AG-120 will be administered at Hour 0 followed by PK sampling for 504 hours...
What is the current status of trial NCT02831972?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2016-06. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02831972?
The interventions under investigation include: Itraconazole (DRUG), AG120 (DRUG).
Who is sponsoring clinical trial NCT02831972?
This trial is sponsored by Agios Pharmaceuticals, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.